We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Trial Data Standards Plan Has NDA, BLA Implications
FDA Trial Data Standards Plan Has NDA, BLA Implications
November 7, 2013
An FDA plan detailing how the agency will develop and implement clinical trial data terminology standards for therapeutic areas (TA), which was released last month, could affect the way drug and biologic applications are reviewed.